0001683168-22-006431.txt : 20220915 0001683168-22-006431.hdr.sgml : 20220915 20220915171158 ACCESSION NUMBER: 0001683168-22-006431 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220915 FILED AS OF DATE: 20220915 DATE AS OF CHANGE: 20220915 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thramann Jeffrey John CENTRAL INDEX KEY: 0001846997 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41358 FILM NUMBER: 221246426 MAIL ADDRESS: STREET 1: 8580 STRAWBERRY LANE CITY: NIWOT STATE: CO ZIP: 80503 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aclarion, Inc. CENTRAL INDEX KEY: 0001635077 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 473324725 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8181 ARISTA PLACE STREET 2: STE 100 CITY: BROOMFIELD STATE: CO ZIP: 80021 BUSINESS PHONE: 833 275 2266 MAIL ADDRESS: STREET 1: 8181 ARISTA PLACE STREET 2: STE 100 CITY: BROOMFIELD STATE: CO ZIP: 80021 FORMER COMPANY: FORMER CONFORMED NAME: Nocimed, Inc. DATE OF NAME CHANGE: 20150226 4 1 ownership.xml X0306 4 2022-09-15 0 0001635077 Aclarion, Inc. ACON 0001846997 Thramann Jeffrey John 8181 ARISTA PLACE SUITE 100 BROOMFIELD CO 80021 1 1 0 0 Executive Chairman Options for Common Stock (right to buy) 1.94 2022-09-15 4 A 0 185285 0.00 A 2031-09-27 Common Stock 185285 1390104 D The shares underlying this option are fully vested. In accordance with the reporting person's employment agreement, on September 27, 2021 the reporting person was previously granted 1,204,819 options with substantially identical terms to the newly granted options reported herein. The options reported herein were granted in order to satisfy the equity grant target set forth in the reporting person's employment agreement. /s/ Jeff Thramann 2022-09-15